Summary
Japan Post Holdings Co., Ltd. filed a Form 4 with the U.S. Securities and Exchange Commission disclosing the sale of 24,200 shares of Aflac Inc. common stock on April 7, 2026. The sales were executed in two transactions at prices between $109.815 and $110.81 per share, producing total proceeds of approximately $2.67 million. After these dispositions, Japan Post Holdings' direct stake in Aflac stands at 51,889,100 shares.
Transaction details and market snapshot
The reported trades were entered on April 7, 2026, and appear as part of a Form 4 filing with the SEC. The per-share prices for the two trades ranged from $109.815 to $110.81, and the aggregate transaction amount was reported as $2.67 million. At the time of the filing, Aflac's last reported share price was $113.53, with a market capitalization of $58.4 billion and a price-to-earnings ratio of 16.5.
According to InvestingPro analysis cited in the filing, Aflac's stock is trading above its Fair Value estimate. The insurer offers a dividend yield of 2.16% and has increased its dividend for 42 consecutive years — a stat listed as one of six InvestingPro Tips for further examination.
Earnings and analyst context
In corporate results released for the fourth quarter of 2025, Aflac reported adjusted earnings per share of $1.57, below the consensus estimate of $1.70, representing a 7.65% negative surprise. Revenue for the quarter was $4.87 billion, ahead of a projected $4.28 billion, a 13.79% positive surprise versus expectations.
On the analyst front, Barclays has maintained an Underweight rating on Aflac with a price target of $101. Mizuho revised its price target upward to $107 from $104 but retained an Underperform recommendation, citing a valuation roll-forward while still forecasting a negative 6% return based on its models.
Key points
- Japan Post Holdings sold 24,200 Aflac shares in two transactions on April 7, 2026, totaling $2.67 million.
- Aflac's Q4 2025 results were mixed - EPS missed consensus ($1.57 vs $1.70) while revenue beat ($4.87B vs $4.28B).
- Analyst sentiment remains cautious with Barclays at Underweight (PT $101) and Mizuho at Underperform (PT raised to $107 but still projecting a negative return).
Risks and uncertainties
- Valuation risk: InvestingPro indicates Aflac is trading above its Fair Value, which could bear on future returns.
- Earnings volatility: The EPS miss in Q4 2025 underscores potential variability in reported profitability for the insurance sector.
- Analyst pressure: Continued Underweight/Underperform ratings and modestly lower price targets could weigh on investor sentiment.
These developments are relevant to investors tracking large institutional holders, insurance-sector fundamentals, and near-term market sentiment. The transaction filing and the company's quarterly disclosure provide the factual basis for evaluating ownership changes and recent financial performance.